Journal Articles

Publication Date

1-1-2023

Journal

Microbial Drug Resistance

Abstract

Recurrent urinary tract infections (UTIs) are a challenging clinical entity that can be frustrating for patient and physician alike. Repeated rounds of antibiotics can select for multidrug-resistant organisms, further complicating care. We describe the successful use of fecal microbiota transplantation (FMT) for the treatment of recurrent extended-spectrum β-lactamase (ESBL)-producing

Keywords

Humans, Klebsiella pneumoniae, Fecal Microbiota Transplantation, Anti-Bacterial Agents, Microbial Sensitivity Tests, Urinary Tract Infections, beta-Lactamases

Included in

Public Health Commons

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.